Erlotinib/afatinibDevelopment of resistance in small cell lung cancer: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1560卷 / 1期

关键词：

D O I：

10.1007/s40278-015-3457-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：85 / 85

相关论文

共 50 条

[1] AfatinibDevelopment of resistance in adeno-squamous cell lung cancer: case report
Reactions Weekly, 2019, 1734 (1) : 22 - 22
[2] Erlotinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2020, 1811 (1) : 123 - 123
[3] Afatinib/erlotinib/gefitinibAcquired resistance in non-small cell lung cancer: case report
Reactions Weekly, 2018, 1705 (1) : 15 - 15
[4] Erlotinib/gefitinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2021, 1850 (1) : 131 - 131
[5] AfatinibDevelopment of afatinib resistance in lung adenocarcinoma: case report
Reactions Weekly, 2016, 1619 (1) : 17 - 17
[6] AfatinibDevelopment of resistance: case report
Reactions Weekly, 2021, 1866 (1) : 20 - 20
[7] AfatinibDevelopment of resistance in stage IV lung adenocarcinoma: case report
Reactions Weekly, 2017, 1647 (1) : 17 - 17
[8] ErlotinibDevelopment of erlotinib resistance in non small cell lung cancer followed by disease progression and dermatotoxicity: case report
Reactions Weekly, 2017, 1658 (1) : 185 - 185
[9] Apatinib/dabigatran etexilate/erlotinibDevelopment of erlotinib resistance in non small cell lung cancer and subcutaneous bleeding: case report
Reactions Weekly, 2017, 1656 (1) : 61 - 61
[10] Erlotinib/gefitinibAcquired resistance in non-small cell lung cancer: 19 case reports
Reactions Weekly, 2018, 1711 (1) : 117 - 117

← 1 2 3 4 5 →